COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

UC San Diego Researcher Awarded $3.8 Million for New Path to Breast Cancer Therapy

 

September 29, 2010  |  

Seth Field, MD, PhD, associate professor in the Department of Medicine at UC San Diego, has been awarded a five-year, $3.86 million “Era of Hope Scholar Award” from the Department of Defense Breast Cancer Research Program.  The award supports individuals who have high potential for innovation in breast cancer research early in their careers, researchers considered the “best and brightest” in their field through “extraordinary creativity, vision and productivity and potential for leadership in the breast cancer research community.

Seth Field

Seth Field, MD, PhD

Field was one of two scientists selected in the global competition.  His project “A New Path to Breast Cancer Therapy” will investigate the mechanism by which a lipid-binding protein called GOLPH3 contributes to cancer.

Recently, Field and colleagues discovered part of the mechanism involving GOLPH3 by which cells export proteins. Interestingly, the gene that encodes GOLPH3 is also a cancer gene that is commonly amplified in human cancers, including approximately one third of breast cancers. Although unprecedented, the identification of GOLPH3 as a cancer gene – together with his discovery of its role in a three-way interaction that is required for efficient extracellular transport – implicates the process of protein export in the development of cancer.

This award will fund experiments to determine the mechanism by which GOLPH3 causes cancer, the role of protein export in this process, and the suitability of the GOLPH3 pathway as a candidate target for new types of breast cancer therapy.

In 2008, Field was a winner of the NIH New Innovator award to study the function of the group of lipid signaling molecules called phosphoinositides and their target proteins such as GOLPH3.  These are molecules which are known to play critical roles in regulating cell growth and death, metabolism, and communication processes within cells. 

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu

 


Related Specialties

Cancer



Media Contact

Share This Article


Related News

7/28/2021
Obesity is a major public health issue among Latinos, and a risk factor for Alzheimer’s disease. But in a new study, researchers at UC San Diego report that cardiometabolic abnormalities, such as hype ...
7/28/2021
Cardiovascular physicians with UC San Diego Health have joined an international clinical trial utilizing a new Extravascular Implantable Cardioverter-Defibrillator (EV ICD) system to help treat sudden ...
7/26/2021
UC San Diego Health, the region’s only academic health system, is ranked #1 in San Diego and #5 in California, placing it among the nation’s best hospitals, according to the 2021-2022 U.S. News & Worl ...
7/23/2021
Senate President Pro Tempore Toni Atkins visited UC San Diego Medical Center today to recognize a $30 million allocation in the 2021-2022 California state budget that will support the redevelopment of ...



Follow Us